Grand Rounds: Hysterectomy sans oophorectomy: The case for leaving a woman's ovaries alone


If there's no cancer present, why remove a woman's ovaries during hysterectomy? Does the reduced risk of ovarian cancer outweigh the consequences of eliminating the protective hormones secreted by a healthy pair of ovaries? A team of researchers offers some thought-provoking conclusions.

The cumulative lifetime mortality rate for women from ovarian cancer after hysterectomy for benign disease is 0.47%, or fewer than one in 200. This is lower than the often-stated lifetime risk of one in 70, a number that includes women with BRCA1 or BRCA2 mutations or other high-risk germ-line mutations.

Despite these important health concerns, many women feel that they do not have enough information about long-term risks and benefits to help them make a decision regarding the prophylactic removal of ovaries when they are having a hysterectomy for benign disease.3 A recent decision analysis for women with inherited BRCA1/2 mutations and at high risk for ovarian cancer (and breast cancer) found that prophylactic oophorectomy was clearly beneficial after completion of childbearing.4 But a recommendation for women with average risk of ovarian cancer has not been established.

The ideal way to study this issue would be with a prospective, randomized trial. However, to be statistically valid and yield meaningful outcomes, such a study would require 8,000 women randomized to oophorectomy or ovarian conservation and then followed for 40 years. So it's unlikely that outcomes will ever be studied in this way.

Related Videos
One year out: Fezolinetant displays patient satisfaction for managing hot flashes | Image Credit:
Addressing maternal health inequities: Insights from CDC's Wanda Barfield | Image Credit:
Addressing racial and ethnic disparities in brachial plexus birth Injury | Image Credit:
Innovations in prenatal care: Insights from ACOG 2024 | Image Credit:
Unlocking therapeutic strategies for menopausal cognitive decline | Image Credit:
Navigating menopause care: Expert insights from ACOG 2024 | Image Credit:
raanan meyer, md
New data shows elinzanetant's efficacy in treating menopausal symptoms | Image Credit:
Related Content
© 2024 MJH Life Sciences

All rights reserved.